Preventative Strategies in the Management of ROP: A Review of Literature

DOI: 10.4236/ojped.2015.52018   PDF   HTML   XML   4,347 Downloads   5,266 Views   Citations


Retinopathy of prematurity (ROP) is a potentially blinding eye disorder that primarily affects premature infants weighing 1250 grams or less that are born before 31 weeks of gestation. It is one of the most common causes of visual loss in childhood and can lead to lifelong vision impairment and blindness. Certain strategies for prevention have been confirmed by numerous trials, namely the role of oxygen therapy as an independent risk factor for the development of ROP and the benefits of strict control of premature infant oxygen saturations in the NICU. There is valuable data that supports use of other approaches, such as beta adrenergic blockade and IGF-1 supplementation, for which clinical trials are still in the works to establish clear protocols for their clinical use. Supplementation with vitamin A, omega-3 fatty acids, and inositol are all exciting arenas for further trials as preliminary data shows promising results in ROP prevention. It has also been shown that the benefit of vitamin E is not worth the increased incidence of NEC and sepsis as potential side effects. Furthermore, while it was an interesting idea to use the chelator D-penicillamine as a preventative strategy for ROP, the results of multiple trials seemed to be equivocal. This brief review is not all-inclusive, as there are many more modes of prevention currently being studied.

Share and Cite:

Livshitz, I. (2015) Preventative Strategies in the Management of ROP: A Review of Literature. Open Journal of Pediatrics, 5, 121-127. doi: 10.4236/ojped.2015.52018.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] National Eye Institute: Facts about Retinopathy of Prematurity (ROP).
[2] Fleck, B.W. and McIntosh, N. (2008) Pathogenesis of Retinopathy of Prematurity and Possible Preventive Strategies. Early Human Development, 84, 83-88.
[3] Penn, J.S., Madan, A., Caldwell, R.B., Bartoli, M., Caldwell, RW. and Hartnett, M.E. (2008) Vascular Endothelial Growth Factor in Eye Disease. Progress in Retinal and Eye Research, 27, 331-371.
[4] Filippi, L., Cavallaro, G., Bagnoli, P., Dal Monte, M., Fiorini, P., Donzelli, G., Tinelli, F., Araimo, G., Cristofori, G., La Marca, G., Della Bona, M.L., La Torre, A., Fortunato, P., Furlanetto, S., Osnaghi, S. and Mosca, F. (2010) Study Protocol: Safety and Efficacy of Propranolol in Newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491. BMC Pediatrics, 10, 83.
[5] Tin, W., Milligan, D.W., Pennefather, P. and Hey, E. (2001) Pulse Oximetry, Severe Retinopathy, and Outcome at One Year in Babies of Less than 28 Weeks Gestation. Archives of Disease in Childhood—Fetal and Neonatal Edition, 84, F106-F110.
[6] VanderVeen, D.K., Mansfield, T.A. and Eichenwald, E.C. (2006) Lower Oxygen Saturation Alarm Limits Decrease the Severity of Retinopathy of Prematurity. Journal of AAPOS, 10, 445-448.
[7] Chow, C., Wright, K.W. and Sola, A. (2003) Can Changes in Clinical Practice Decrease the Incidence of Severe Retinopathy of Prematurity in Very Low Birth Weight Infants? Pediatrics, 111, 339-345.
[8] Wright, K.W., Sami, D., Thompson, L., Ramanathan, R. and Joseph, R. (2006) A Physiologic Reduced Oxygen Protocol Decreases the Incidence of Threshold Retinopathy of Prematurity. Transactions of the American Ophthalmological Society, 104, 78-84.
[9] Sink, D., Thomas, P., Bober, B. and Hagadom, J.I. (2012) Oxygen with Love (OWL) Improves Oxygen Saturation Target Achievement and Eye Outcomes in Preterm Newborn.
[10] Raghuveer, T.S. and Bloom, B.T. (2011) A Paradigm Shift in the Prevention of Retinopathy of Prematurity. Neonatology, 100, 116-129.
[11] The STOP-ROP Multicenter Study Group (2000) Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP): A Randomized, Controlled Trial. I: Primary Outcome. Pediatrics, 105, 295-310.
[12] Cavallaro, G., Filippi, L., Bagnoli, P., La Marca, G., Cristofori, G., Raffaeli, G., Padrini, L., Araimo, G., Fumagalli, M., Groppo, M., Dal Monte, M., Osnaghi, S., Fiorini, P. and Mosca, F. (2014) The Pathophysiology of Retinopathy of Prematurity: An Update of Previous and Recent Knowledge. Acta Ophthalmologica, 92, 2-20.
[13] Filippi, L., Cavallaro, G., Bagnoli, P., Dal Monte, M., Fiorini, P., Donzelli, G., Tinelli, F., Araimo, G., Cristofori, G., la Marca, G., Della Bona, M.L., La Torre, A., Fortunato, P., Furlanetto, S., Osnaghi, S. and Mosca, F. (2013) Oral Propranolol for Retinopathy of Prematurity: Risks, Safety Concerns, and Perspectives. The Journal of Pediatrics, 163, 1570-1577.
[14] Makhoul, I.R., Peleg, O., Miller, B., Bar-Oz, B., Kochavi, O., Mechoulam, H., Mezer, E., Ulanovsky, I., Smolkin, T., Yahalom, C., Khoury, A., Lorber, A., Nir, A. and Blazer, S. (2013) Oral Propranolol versus Placebo for Retinopathy of Prematurity: A Pilot, Randomised, Double-Blind Prospective Study. Archives of Disease in Childhood, 98, 565-567.
[15] Dal Monte, M., Casini, G., la Marca, G., Isacchi, B., Filippi, L. and Bagnoli, P. (2013) Eye Drop Propranolol Administration Promotes the Recovery of Oxygen-Induced Retinopathy in Mice. Experimental Eye Research, 111, 27-35.
[16] Mactier, H., McCulloch, D., Hamilton, R., Galloway, P., Bradnam, M.S., Young, D., Lavy, T., Farrell, L. and Weaver, L.T. (2012) Vitamin A Supplementation Improves Retinal Function in Infants at Risk of Retinopathy of Prematurity. The Journal of Pediatrics, 160, 954-959.
[17] Wang, L., Shi, P., Xu, Z., Li, J., Xie, Y., Mitton, K., Drenser, K. and Yan, Q. (2014) Up-Regulation of VEGF by Retinoic Acid during Hyperoxia Prevents Retinal Neovascularization and Retinopathy. Investigative Ophthalmology & Visual Science, 55, 4276-4287.
[18] Brion, L.P., Bell, E.F. and Raghuveer, T.S. (2003) Vitamin E Supplementation for Prevention of Morbidity and Mortality in Preterm Infants. Cochrane Database of Systematic Reviews, Article ID: CD003665.
[19] Johnson, L., Quinn, G.E., Abbasi, S., Otis, C., Goldstein, D., Sacks, L., Porat, R., Fong, E., Delivoria-Papadopoulos, M., Peckham, G., et al. (1989) Effect of Sustained Pharmacologic Vitamin E Levels on Incidence and Severity of Retinopathy of Prematurity: A Controlled Clinical Trial. The Journal of Pediatrics, 114, 827-838.
[20] Phelps, D.L., Rosenbaum, A.L., Isenber, S.J., Leake, R.D. and Dorey, F.J. (1987) Tocopherol Efficacy and Safety for Preventing Retinopathy of Prematurity: A Randomized, Controlled, Double-Masked Trial. Pediatrics, 79, 489-500.
[21] Smith, L.E.H. (2008) Through the Eyes of a Child: Understanding Retinopathy through ROP the Friedenwald Lecture. Investigative Ophthalmology & Visual Science, 49, 5177-5182.
[22] Hellstrom, A., Engstrom, E., Hard, A.L., Albertsson-Wikland, K., Carlsson, B., Niklasson, A., L?fqvist, C., Svensson, E., Holm, S., Ewald, U., Holmstrom, G. and Smith, L.E. (2003) Postnatal Serum Insulin-Like Growth Factor I Deficiency Is Associated with Retinopathy of Prematurity and Other Complications of Premature Birth. Pediatrics, 112, 1016-1020.
[23] Lofqvist, C., Engstrom, E., Sigurdsson, J., Hard, A.L., Niklasson, A., Ewald, U., et al. (2006) Postnatal Head Growth Deficit among Premature Infants Parallels Retinopathy of Prematurity and Insulin-Like Growth Factor-I Deficit. Pediatrics, 117, 1930-1938.
[24] Dani, C., Poggi, C., Bresci, C., Corsini, I., Frosini, S. and Pratesi, S. (2014) Early Fresh-Frozen Plasma Transfusion Decreases the Risk of Retinopathy of Prematurity. Transfusion, 54, 1002-1007.
[25] Connor, K.M., SanGiovanni, J.P., Lofqvist, C., Aderman, C.M., Chen, J., Higuchi, A., et al. (2007) Increased Dietary Intake of ω-3-Polyunsaturated Fatty Acids Reduces Pathological Retinal Angiogenesis. Nature Medicine, 7, 868-873.
[26] Qawasmi, A., Landeros-Weisenberger, A. and Bloch, M.H. (2013) Meta-Analysis of LCPUFA Supplementation of Infant Formula and Visual Acuity. Pediatrics, 131, e262-e272.
[27] Mantagos, I.S., Vanderveen, D.K. and Smith, L.E. (2009) Emerging Treatments for Retinopathy of Prematurity. Seminars in Ophthalmology, 24, 82-86.
[28] Phelps, D.L., Lakatos, L. and Watts, J.L. (2001) D-Penicillamine for Preventing Retinopathy of Prematurity in Preterm Infants. Cochrane Database of Systematic Reviews, Article ID: CD001073.
[29] Qureshi, M.J. and Kumar, M. (2013) D-Penicillamine for Preventing Retinopathy of Prematurity in Preterm Infants. Cochrane Database of Systematic Reviews, 9, Article ID: CD001073.
[30] Hylander, M.A., Strobino, D.M., Pezzullo, J.C. and Dhanireddy, R. (2001) Association of Human Milk Feedings with a Reduction in Retinopathy of Prematurity among Very Low Birth-Weight Infants. Journal of Perinatology, 21, 356-362.
[31] Friedman, C.A., McVey, J., Borne, M.J., James, M., May, W.L., Temple, D.M., Robbins, K.K., Miller, C.J. and Rawson, J.E. (2000) Relationship between Serum Inositol Concentration and Development of Retinopathy of Prematurity: A Prospective Study. Journal of Pediatric Ophthalmology & Strabismus, 37, 79-86.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.